Literature DB >> 11213112

What can be achieved with an HIV vaccine?

J A Levy1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11213112     DOI： 10.1016/S0140-6736(00)03601-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  A susceptible-infected epidemic model with voluntary vaccinations.

Authors:  Frederick H Chen
Journal:  J Math Biol       Date:  2006-06-07       Impact factor: 2.259

2.  HIV vaccine knowledge and beliefs among communities at elevated risk: conspiracies, questions and confusion.

Authors:  Kathleen Johnston Roberts; Peter A Newman; Naihua Duan; Ellen T Rudy
Journal:  J Natl Med Assoc       Date:  2005-12       Impact factor: 1.798

3.  What can HIV vaccine trials teach us about future HIV vaccine dissemination?

Authors:  Peter A Newman; Naihua Duan; Lisa Kakinami; Kathleen Roberts
Journal:  Vaccine       Date:  2008-03-28       Impact factor: 3.641

4.  HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics.

Authors:  Peter A Newman; Naihua Duan; Sung-Jae Lee; Ellen T Rudy; Danielle S Seiden; Lisa Kakinami; William E Cunningham
Journal:  Vaccine       Date:  2005-11-21       Impact factor: 3.641

5.  HIV vaccine acceptability among immigrant Thai residents in Los Angeles: a mixed-method approach.

Authors:  Sung-Jae Lee; Ronald A Brooks; Peter A Newman; Danielle Seiden; Rassamee Sangthong; Naihua Duan
Journal:  AIDS Care       Date:  2008-11

6.  Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: A South African example.

Authors:  Kyeen M Andersson; Douglas K Owens; Eftyhia Vardas; Glenda E Gray; James A McIntyre; A David Paltiel
Journal:  J Acquir Immune Defic Syndr       Date:  2007-09-01       Impact factor: 3.731

7.  Cost-effectiveness of male circumcision for HIV prevention in a South African setting.

Authors:  James G Kahn; Elliot Marseille; Bertran Auvert
Journal:  PLoS Med       Date:  2006-12       Impact factor: 11.069
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.